Long intergenic non-protein coding RNA 51 (LINC00051)

Long intergenic non-protein coding RNA 51 (LINC00051) is a member of the long non-coding RNA (lncRNA) family. It is transcribed from a region of the human genome (not encoding protein) and is annotated by sources such as GeneCards and BioGPS as a non-protein coding RNA[1][3]. In general, lncRNAs are regulatory RNA molecules involved in diverse cellular processes via gene expression modulation, epigenetic regulation, and interaction with chromatin due to their non-coding nature[5]. However, there is no literature currently linking LINC00051 specifically to canonical biological functions, disease mechanisms, or clinical use as a biomarker or therapeutic target. No interaction with drugs or described mechanism of action is reported. Note on possible confusion: LINC00051 is a distinct entity and should not be confused with functionally characterized lncRNAs such as LINC01116 or other family members, which are therapeutically relevant in cancer[2][5]. No source currently identifies LINC00051 as a therapeutic target or describes any safety or efficacy concerns; it remains only an annotated lncRNA genomic locus without characterized biology or disease association[1][3]. Summary: LINC00051 is an uncharacterized long non-coding RNA not currently considered a therapeutic target; there is no evidence for a direct role in disease or interaction with any drugs[1][3].

Other names

C8orf43NCRNA00051LINC00051